What is the exact half-life of Testosterone Propionate and why does it matter for dosing schedules?

Testosterone Propionate carries a plasma half-life of approximately 48–72 hours, meaning the circulating concentration halves every two to three days. This short half-life necessitates injections every second or third day to maintain stable androgenic blood levels. Missing a scheduled injection produces a more pronounced trough than would occur with a long-ester formulation, making adherence to the injection timetable central to achieving consistent results.

How many injections are needed before Testosterone Propionate reaches pharmacokinetic steady-state?

Steady-state plasma testosterone is typically reached after approximately three consecutive injection intervals — usually by day 7–10 of an every-other-day protocol. At steady-state, each dose replaces precisely the amount cleared since the previous injection, stabilising the peak-to-trough ratio. This is faster than enanthate, which requires up to three weeks to reach comparable equilibrium, making propionate advantageous for short cycles where time-to-effective-level matters.

How quickly do blood testosterone levels fall after the last Testosterone Propionate injection?

With a half-life of roughly 48–72 hours, measurable exogenous testosterone declines to near-baseline within approximately 4–5 days after the final injection. This rapid clearance is a pharmacokinetic advantage for users who need to time post-cycle therapy or approach a drug-tested event, as the window between last injection and hormonal washout is significantly shorter than with cypionate or enanthate esters.

Can a standard insulin syringe be used to draw from Genesis Test-prop 100's 10 ml vial, and how should the vial be stored after first use?

Yes — at 100 mg/ml, a 1 ml insulin syringe accommodates doses from 25 mg (0.25 ml) up to 100 mg (1 ml) with clear graduation markings. After the rubber stopper is first punctured, store the vial at 15–25°C away from direct light; avoid refrigeration of oil-based injectables as cooling can cause the carrier oil to thicken and impede accurate drawing. Discard the vial within 28 days of first use or per the product's in-use stability data.

How does the 100 mg/ml concentration of Genesis Test-prop 100 affect injection volume compared to higher-concentration propionate products?

At 100 mg/ml, a 100 mg dose requires exactly 1 ml of injection volume — straightforward to measure but slightly larger than the 0.67 ml required by a 150 mg/ml formulation for the same dose. For users injecting every other day, the modest volume difference is clinically insignificant, and 100 mg/ml is considered the benchmark concentration for pharmacokinetic reference studies, making dose-to-plasma-level projections directly comparable to published clinical data. (2) angle_used

Top Seller

Genesis

Test-prop 100 100mg/ml 10ml Vial by Genesis

Name: Test-prop 100 100mg/ml 10ml Vial by Genesis
Brand: Genesis
SKU: INJ-TPRO-GES-100-008
Price: 28.00 EUR
Availability: InStock

Genesis Test-prop 100 is a 100 mg/ml Testosterone Propionate injectable solution supplied in a 10 ml multi-dose vial, characterised by a plasma half-life of approximately 2–3 days that governs a predictable, short-cycle release profile suited to frequent-dosing protocols. The abbreviated ester kinetics mean that circulating testosterone levels respond rapidly to each dose adjustment, giving users tighter control over their androgenic environment than longer-ester formulations permit. Batch integrity is confirmed through HPLC potency verification and LAL endotoxin testing — both conducted at the finished-product stage under GMP-certified fill-finish conditions.

€28.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Rapid hormonal adjustability enabled by a sub-72-hour half-life that responds to dose changes within days
Predictable peak-to-trough ratio when dosed on a consistent every-other-day schedule
Fast exogenous testosterone clearance supports precise post-cycle timing
Standard 100 mg/ml concentration aligns with published pharmacokinetic reference data for accurate projections
Multi-dose 10 ml vial format provides economical supply for full short-ester cycles
HPLC-confirmed potency at the finished-product stage ensures labelled concentration matches actual content
GMP-certified fill-finish and LAL endotoxin verification underpin vial-to-vial reproducibility

Phase	Dosage	Note
Kinetic Loading (Days 1–7)	100 mg every other day (EOD)	Establishes circulating propionate levels; steady-state approached by day 7–10 based on the 48–72h half-life
Maintenance (Weeks 2–8)	75–100 mg EOD	Sustains plasma testosterone within the therapeutic window; frequency driven by half-life — do not extend intervals beyond 3 days
Taper & Clearance (Final 5–7 days)	50–75 mg EOD, then cease	Short half-life means exogenous testosterone clears within ~5 days of last injection, enabling prompt PCT initiation

Key takeaways

Expect a plasma half-life of 48–72 hours, demanding consistent every-other-day injections.
Reach pharmacokinetic steady-state approximately three injection intervals faster than enanthate.
Adjust doses confidently — plasma corrections become measurable within 3–4 days.
Verify HPLC and LAL batch documentation to ensure kinetic projections remain accurate.
Plan post-cycle therapy to begin within 5 days of the final propionate injection.

Pharmacokinetic Profile of Testosterone Propionate 100 mg/ml

Genesis Test-prop 100 is a short-ester testosterone injectable whose plasma half-life of roughly 48–72 hours defines every practical aspect of its use: injection frequency, peak-to-trough ratio, and the speed at which blood-level corrections take effect. Unlike enanthate or cypionate, where ester clearance extends over 7–14 days, propionate's abbreviated pharmacokinetic window compresses the absorption-distribution-elimination cycle into a matter of days. This compression is precisely what practitioners value when rapid hormonal adjustability is the priority.

How the Propionate Ester Shapes the Release Curve

Tissue esterases hydrolyse the propionate chain at a rate that produces a concentration-time curve peaking within 24 hours post-injection and declining to sub-therapeutic levels within approximately 4–5 days. In practice, stable steady-state plasma testosterone is achieved after roughly three consecutive injection intervals — typically 3–4 days apart — rather than the two-to-three weeks required by longer esters to reach pharmacokinetic equilibrium. Genesis Test-prop 100 delivers 100 mg of active compound per millilitre, meaning each 1 ml injection contributes a quantifiable testosterone load whose systemic clearance can be projected using the known half-life without laboratory confirmation.

Comparing Propionate Kinetics to Longer Esters

Compared to testosterone enanthate (half-life ~7 days), propionate's shorter half-life reduces the biological lag between a dose change and a measurable plasma response by approximately 4–5 days. This pharmacokinetic agility makes the propionate form the rational choice when cycle duration is short or when the user requires the flexibility to cease androgen exposure and clear exogenous testosterone within one week of the final injection. Genesis formulates the compound at the industry-standard 100 mg/ml concentration — the same density used in controlled clinical half-life studies — which keeps pharmacokinetic calculations straightforward and reproducible.

Quality Framework Supporting Kinetic Predictability

Predictable release kinetics depend on accurate labelled concentration; a batch reading 85 mg/ml instead of 100 mg/ml would shift every pharmacokinetic projection. Genesis addresses this through HPLC potency assay at the finished-product stage, with LAL limulus amebocyte lysate testing confirming endotoxin limits below USP threshold. GMP-certified fill-finish operations govern vial sealing and aseptic transfer, ensuring that the 10 ml multi-dose format maintains sterility across repeated draws throughout the vial's in-use period.

Usage

Confirm vial label reads 100 mg/ml and check the batch certificate of analysis for HPLC potency and LAL endotoxin results before drawing the first dose.
Calculate your target dose in milligrams, then convert to millilitres (e.g. 100 mg ÷ 100 mg/ml = 1.0 ml); use a graduated 1 ml syringe for precision at this concentration.
Allow the vial to reach room temperature (15–25°C) before drawing; oil-based solutions flow more consistently at ambient temperature, reducing the risk of air bubbles that distort measured volume.
Inject intramuscularly — gluteus, vastus lateralis, or deltoid — rotating sites with each EOD injection to prevent tissue accumulation at a single location, which the short half-life's frequent dosing schedule makes especially important.
Adhere strictly to the injection interval dictated by the 48–72 hour half-life: an EOD schedule (Monday–Wednesday–Friday or daily alternation) maintains plasma levels above the effective trough concentration consistently.
Log each injection date, dose, and site; because propionate's kinetics make plasma levels sensitive to missed doses, a written record helps identify any lapse and informs how quickly a correction dose re-establishes steady-state.

Warnings

Contraindications: Testosterone Propionate is contraindicated in individuals with known or suspected androgen-sensitive carcinoma of the prostate or breast, in women who are pregnant or may become pregnant, and in those with hypersensitivity to any component of the formulation including the carrier oil. Polycythaemia, untreated severe sleep apnoea, and uncontrolled congestive heart failure represent additional absolute contraindications.

Side_Effects: Androgenic adverse effects include accelerated hair thinning in genetically predisposed individuals, acne, and virilisation in female users. Aromatisation to oestradiol at higher doses may produce fluid retention or gynaecomastia. The EOD injection schedule inherent to propionate's pharmacokinetics increases the cumulative number of injection-site exposures, raising the likelihood of local soreness, nodule formation, or injection-site bruising compared to weekly long-ester protocols.

Monitoring: Haematocrit, haemoglobin, and red cell mass should be assessed at baseline and every 12 weeks; values exceeding 54 % haematocrit warrant dose reduction or temporary cessation. Serum lipid panels (LDL, HDL) and liver enzyme panels provide surveillance data; PSA measurement is recommended for male users over 40 at baseline and at 3-month intervals. Blood pressure monitoring is appropriate throughout the cycle given sodium-retentive effects of androgenic compounds.

PCT: Because the propionate ester clears plasma within approximately 5 days of the final injection (based on its 48–72 hour half-life), post-cycle therapy with a SERM such as tamoxifen or clomiphene can commence promptly — typically 5–7 days after cessation. A standard PCT window of 4 weeks supports endogenous HPG-axis recovery; HCG administered during the final cycle week may accelerate testicular resensitisation before SERM therapy begins.

Frequently asked questions

What is the exact half-life of Testosterone Propionate and why does it matter for dosing schedules?: Testosterone Propionate carries a plasma half-life of approximately 48–72 hours, meaning the circulating concentration halves every two to three days. This short half-life necessitates injections every second or third day to maintain stable androgenic blood levels. Missing a scheduled injection produces a more pronounced trough than would occur with a long-ester formulation, making adherence to the injection timetable central to achieving consistent results.
How many injections are needed before Testosterone Propionate reaches pharmacokinetic steady-state?: Steady-state plasma testosterone is typically reached after approximately three consecutive injection intervals — usually by day 7–10 of an every-other-day protocol. At steady-state, each dose replaces precisely the amount cleared since the previous injection, stabilising the peak-to-trough ratio. This is faster than enanthate, which requires up to three weeks to reach comparable equilibrium, making propionate advantageous for short cycles where time-to-effective-level matters.
How quickly do blood testosterone levels fall after the last Testosterone Propionate injection?: With a half-life of roughly 48–72 hours, measurable exogenous testosterone declines to near-baseline within approximately 4–5 days after the final injection. This rapid clearance is a pharmacokinetic advantage for users who need to time post-cycle therapy or approach a drug-tested event, as the window between last injection and hormonal washout is significantly shorter than with cypionate or enanthate esters.
Can a standard insulin syringe be used to draw from Genesis Test-prop 100's 10 ml vial, and how should the vial be stored after first use?: Yes — at 100 mg/ml, a 1 ml insulin syringe accommodates doses from 25 mg (0.25 ml) up to 100 mg (1 ml) with clear graduation markings. After the rubber stopper is first punctured, store the vial at 15–25°C away from direct light; avoid refrigeration of oil-based injectables as cooling can cause the carrier oil to thicken and impede accurate drawing. Discard the vial within 28 days of first use or per the product's in-use stability data.
How does the 100 mg/ml concentration of Genesis Test-prop 100 affect injection volume compared to higher-concentration propionate products?: At 100 mg/ml, a 100 mg dose requires exactly 1 ml of injection volume — straightforward to measure but slightly larger than the 0.67 ml required by a 150 mg/ml formulation for the same dose. For users injecting every other day, the modest volume difference is clinically insignificant, and 100 mg/ml is considered the benchmark concentration for pharmacokinetic reference studies, making dose-to-plasma-level projections directly comparable to published clinical data. (2) angle_used

Manufacturer

Genesis has earned its position in the injectable androgen market largely through a pricing strategy that prioritises accessibility without sacrificing formulation standards — a balance that is especially visible in its Test-prop 100 offering. Rather than positioning Testosterone Propionate as a premium-tier product with a correspondingly elevated price point, Genesis prices its 10 ml vials competitively enough to remain within reach of users running the frequent-dosing, higher-injection-count schedules that propionate's pharmacokinetics demand. The economic logic is straightforward: a compound requiring injections every other day across an 8-week cycle consumes more vials than a once-weekly enanthate protocol, so affordability directly influences whether users can sustain correct dosing frequency throughout the full cycle duration. Genesis's cost structure is supported by efficient manufacturing operations governed by GMP certification, where standardised batch sizes and documented raw-material procurement keep per-unit production costs predictable. This cost discipline is passed through to end-users rather than absorbed as margin, which community-sourced purchasing data consistently identifies as the primary reason Test-prop 100 ranks among Genesis's highest-volume SKUs. Certificates of analysis, including HPLC potency figures and LAL endotoxin values, are available for each batch — evidence that accessible pricing coexists with documented quality control rather than substituting for it.

Product details

Brand	Genesis
Active ingredient	testosterone propionate
Also known as	Testosterone Propionate, Test P, Testovis, Test-prop 100, Genesis Testosterone Propionate
Strength	100 mg
Form	Vial
Pack size	1 piece
Item number	INJ-TPRO-GES-100-008

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Propandrol 100mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

Established Brand

Propandrol 100mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Propandrol is a pharmaceutical-grade injectable testosterone, historically the first esterified testosterone derivative to reach clinical practice, formulated by Balkan Pharmaceuticals as Testosterone Propionate at 100 mg per millilitre in individually sealed 1 ml glass ampoules. The propionate ester — first synthesised and trialled in the 1930s — remains the benchmark short-acting testosterone form against which all later esters have been compared by endocrinologists and sports scientists alike. Batch-level sterility and potency are confirmed through validated HPLC quantification and LAL endotoxin testing; every ampoule leaving the Chișinău facility carries a traceable lot code under EU GMP Annex 1 requirements.

€36.00

Optimal Dosage

Propha-Testosterone 100mg/ml 10ml Vial by Beligas Pharmaceuticals

Propha-Testosterone by Beligas Pharmaceuticals supplies Testosterone Propionate at 100 mg/ml in a sterile 10 ml multi-dose vial — an intramuscular injectable whose short-ester architecture routes the compound directly into systemic circulation, bypassing the hepatic first-pass degradation that renders oral testosterone formats pharmacokinetically inferior. Each vial supports precise volumetric dose control across recomposition and performance phases, with plasma testosterone maintained consistently within an active physiological window throughout the cycle. Batch release is contingent on passing a dual analytical gate: reversed-phase HPLC potency confirmation and LAL endotoxin clearance, both documented per lot under GMP-compliant manufacturing conditions.

€35.00

Testopin-100 100mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Fast Acting

Testopin-100 100mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Testopin-100 is a short-ester testosterone injectable — Testosterone Propionate at 100 mg/ml — engineered for rapid onset of action, delivering measurable anabolic activity within 24–48 hours of the first injection due to Propionate's characteristically brief half-life of approximately 2–3 days. Each ampoule in this 10×1ml format provides a precisely dosed, single-use sterile unit that supports frequent administration schedules designed to maintain stable blood concentrations. Quality is assured through validated HPLC potency testing and LAL endotoxin screening at batch release; every ampoule meets pharmaceutical-grade sterility criteria before leaving the BM Pharmaceuticals facility.

€38.00

High Concentration

PropiTrex 150mg/ml 10ml Vial by Concentrex Labs

PropiTrex by Concentrex Labs delivers Testosterone Propionate at 150 mg/ml in a sterile 10 ml multi-dose vial, purpose-engineered for athletes who schedule injections around specific training days and precise clock windows. Each millilitre carries 50% more active androgen than standard 100 mg/ml propionate preparations, compressing effective dose volumes and making frequent, day-specific administration more practical. Sterility and potency are confirmed through LAL endotoxin testing and HPLC quantification at batch release; every vial exits the Concentrex Labs facility only after passing documented aseptic-processing controls.

€35.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00